News
Press Releases
April 10, 2019
NodThera Highlights Significant Progress with Advancement of Lead Development Candidate and Key Additions to Board
– Company advances NT-0167 as first development candidate from a broad platform of NLRP3 inflammasome inhibitors –…
October 23, 2018
NodThera announces the appointment of Alison Strutt PhD as Head of Finance & Operations, the launch of its new corporate office in Boston and the opening of its laboratory in Seattle
– Expansion in the US is consistent with NodThera’s strategy to access world class talent, foster collaborative…
September 23, 2018
NodThera announces the appointment of Adam Keeney PhD as President and Chief Executive Officer
– Dr Keeney joins NodThera with over 20 years of pharmaceutical industry experience, including most recently at…
April 10, 2019
NodThera Highlights Significant Progress with Advancement of Lead Development Candidate and Key Additions to Board
– Company advances NT-0167 as first development candidate from a broad platform of NLRP3 inflammasome inhibitors –…
October 23, 2018
NodThera announces the appointment of Alison Strutt PhD as Head of Finance & Operations, the launch of its new corporate office in Boston and the opening of its laboratory in Seattle
– Expansion in the US is consistent with NodThera’s strategy to access world class talent, foster collaborative…
September 23, 2018
NodThera announces the appointment of Adam Keeney PhD as President and Chief Executive Officer
– Dr Keeney joins NodThera with over 20 years of pharmaceutical industry experience, including most recently at…
June 25, 2018
NodThera secures £28 million ($40 million) Series A Financing
– NodThera discovers and develops next generation NLRP3 inflammasome inhibitors for the treatment of diseases driven by…
July 28, 2016
Epidarex Capital Creates Nodthera Limited
A pioneering new company based on Selvita research and utilizing novel immunological approaches to disease Edinburgh, Scotland,…
Media Contact
Max Stendahl
Ten Bridge Communications
max@tenbridgecommunications.com
(508) 277-8117
For all other company inquiries, contact us at info@nodthera.com.
